Pregnant women should get flu shots

Pregnant women need flu shots — it’s safe to get an influenza (flu) shot during pregnancy. – Pregnant women should be sure to get all their flu shots as soon as the vaccines become available this year to protect them against both the seasonal flu and the H1N1 (swine) flu.

New learning guidance in case of Flu outbreak, US

Duncan, Sebelius Unveil Recommendations for Schools on How Learning Continues in Case of Flu Outbreak – US Department of Education is suggesting to help education stakeholders start planning and acting now for the impact that seasonal and 2009 H1N1 influenza could have this fall and winter on schools and the learning process.

CDC guidelines for seasonal and swine flu vaccines questioned

Yale researcher questions federal guidelines for seasonal and swine flu vaccines – With the seasonal flu season approaching and uncertainty over whether swine flu will become more severe, new research published by Yale School of Public Health has found that more people are likely to avoid illness if vaccines are given out first to those most likely to transmit viruses, rather than to those at highest risk for complications.

US to launch clinical trials to test 2009 H1N1 influenza vaccine

NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidates – Scientists in a network of medical research institutions across the United States are set to begin a series of clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines.

Seasonal influenza vaccine for 2009-2010 approved by US

U.S. Food and Drug Administration (FDA) Approves Vaccine for 2009-2010 Seasonal Influenza. – The U.S. Food and Drug Administration announced that it has approved a vaccine for 2009-2010 seasonal influenza in the United States. The seasonal influenza vaccine will not protect against the 2009 H1N1 influenza virus.

$884 million to purchase H1N1 vaccine, US

HHS Purchases Additional H1N1 Vaccine Ingredients – U.S. Department of Health & Human Services’ Secretary Kathleen Sebelius announced that the health department will commit $884 million to purchase additional supplies of two key ingredients for potential H1N1 vaccine to further prepare the nation for a potential resurgence of the 2009 H1N1 virus.

Gardasil is eligible for UN immunization programs

GARDASIL? is First Cervical Cancer Vaccine to Receive WHO Pre-qualification — WHO Pre-qualification Will Help to Facilitate Expanded Global Access and Implementation of HPV Vaccination Programs. – GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck’s cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification. GARDASIL is the first cervical cancer vaccine to receive WHO pre-qualification.

Infant pain response depends on order of administration of vaccine

Infant pain response during routine intramuscular vaccine injection was affected by the order of administration of the vaccine. – Infants who receive the pneumococcal conjugate vaccine (PCV) following the combination vaccine for diphtheria, polio, tetanus, pertussis and Haemophilus influenzae type b (DPTaP-Hib vaccine) appear to experience less pain than those who are immunized in the opposite order, according to a report in the May issue of Archives of Pediatrics & Adolescent Medicine, a theme issue on vaccines.

Mayo Clinic Health Manager powered by Microsoft HealthVault

Mayo Clinic and Microsoft deliver a powerful and personalized consumer solution for managing health. Mayo Clinic Health Manager, powered by Microsoft HealthVault, helps you and your family become better organized, better informed. – Mayo Clinic and Microsoft Corp. announced the launch of Mayo Clinic Health Manager, a privacy- and security-enhanced free online application that provides people with a place to store medical information and receive real-time individualized health guidance and recommendations based on the clinical expertise of Mayo Clinic.

Ixiaro to prevent Japanese Encephalitis approved in Europe

European Commission grants marketing authorization for Intercell?s IXIARO, the first licensed vaccine against Japanese Encephalitis for travelers and military personnel in Europe. – Intercell AG (VSE: ICLL) announced that its new vaccine to prevent Japanese Encephalitis, IXIARO, has been approved by the European Commission.

Health Newstrack